Line Bisgaard

Line Bisgaard serves as a Teaching Assistant Professor and Guest Researcher in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. Her academic work spans both teaching responsibilities and active research in cardiovascular and kidney disease mechanisms, with particular focus on macrophage phenotypes in atherosclerotic plaques and the relationship between kidney disease and accelerated atherosclerosis.

• M.Sc., Molecular Biomedicine, University of Copenhagen (2010)

Dr. Bisgaard's research program centers on two primary areas: investigating macrophage phenotype composition in atherosclerotic plaques compared to in vitro models, and examining mechanisms underlying acceleration of atherosclerosis in relation to kidney disease. She specifically explores whether development of insulin resistance explains the accelerated atherogenesis observed in kidney disease patients. Her work bridges cardiovascular biology and nephrology, with strong emphasis on molecular mechanisms and biomarker discovery.

Analysis of her 15 most recent publications (2021-2025) reveals a consistent research trajectory focused on the intersection of cardiovascular disease and kidney pathology. The publications demonstrate expertise in metabolomics, biomarker identification, and molecular pathways linking kidney dysfunction to cardiovascular complications. Key recurring themes include apolipoprotein M research, macrophage biology in atherosclerosis, and metabolic signatures of disease progression.

Dr. Bisgaard maintains active research collaborations across multiple institutions, as evidenced by her co-authorship on publications with researchers from diverse specialties including cardiology, nephrology, and molecular biology. Her work appears in high-impact journals such as Arteriosclerosis, Thrombosis, and Vascular Biology, Clinical Nutrition, and Atherosclerosis.

Her laboratory work is conducted within the Physiology of circulation, kidney and lung research group at the Department of Biomedical Sciences, University of Copenhagen, with additional connections to the Diabetes Complications Biology department at Novo Nordisk where she conducts part of her PhD research.